Bernhard Scheiner
Has participated in:
-
Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab
-
Reply to the Letter to the Editor Entitled “Too Many versus Too Few Platelets in Patients with Hepatocellular Carcinoma: Good or Bad?”
-
Response to the Letter to the Editor Concerning the Publication “Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable...
-
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma